DE69427484D1 - Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma - Google Patents

Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma

Info

Publication number
DE69427484D1
DE69427484D1 DE69427484T DE69427484T DE69427484D1 DE 69427484 D1 DE69427484 D1 DE 69427484D1 DE 69427484 T DE69427484 T DE 69427484T DE 69427484 T DE69427484 T DE 69427484T DE 69427484 D1 DE69427484 D1 DE 69427484D1
Authority
DE
Germany
Prior art keywords
monoclonal antibodies
hybridoma
angiotensin
receptor type
specific monoclonal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69427484T
Other languages
English (en)
Other versions
DE69427484T2 (de
Inventor
Gavin Paul Vinson
Stewart Barker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Queen Mary University of London
Original Assignee
Queen Mary and Westfiled College University of London
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10742573&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69427484(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Queen Mary and Westfiled College University of London filed Critical Queen Mary and Westfiled College University of London
Application granted granted Critical
Publication of DE69427484D1 publication Critical patent/DE69427484D1/de
Publication of DE69427484T2 publication Critical patent/DE69427484T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Urology & Nephrology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69427484T 1993-09-27 1994-09-27 Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma Expired - Lifetime DE69427484T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939319877A GB9319877D0 (en) 1993-09-27 1993-09-27 Novel hybridoma & monoclonal antibodies produced thereby
PCT/GB1994/002100 WO1995009186A1 (en) 1993-09-27 1994-09-27 Type i angiotensin ii receptor specific monoclonal antibodies and hybridomas

Publications (2)

Publication Number Publication Date
DE69427484D1 true DE69427484D1 (de) 2001-07-19
DE69427484T2 DE69427484T2 (de) 2002-09-12

Family

ID=10742573

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69427484T Expired - Lifetime DE69427484T2 (de) 1993-09-27 1994-09-27 Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma

Country Status (9)

Country Link
US (2) US6063620A (de)
EP (1) EP0725798B1 (de)
JP (1) JP3727946B2 (de)
AT (1) ATE202117T1 (de)
AU (1) AU695074B2 (de)
CA (1) CA2170606C (de)
DE (1) DE69427484T2 (de)
GB (1) GB9319877D0 (de)
WO (1) WO1995009186A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9319877D0 (en) * 1993-09-27 1993-11-10 Queen Mary Novel hybridoma & monoclonal antibodies produced thereby
GB9410639D0 (en) * 1994-05-27 1994-07-13 Queen Mary & Westfield College Method of improving fertilization
CA2314811A1 (en) * 2000-08-02 2002-02-02 Brian Archibald Macvicar Autoimmunity to angiotensin at1 receptors in schizophrenia
US20030187495A1 (en) 2002-04-01 2003-10-02 Cully Edward H. Endoluminal devices, embolic filters, methods of manufacture and use
GB0219524D0 (en) * 2002-08-21 2002-10-02 Queen Mary & Westfield College Therapeutic uses of monoclonal antibodies to the angiotensin-II type-1 receptor
US20040093012A1 (en) 2002-10-17 2004-05-13 Cully Edward H. Embolic filter frame having looped support strut elements
US9149609B2 (en) * 2006-10-16 2015-10-06 Embolitech, Llc Catheter for removal of an organized embolic thrombus
WO2009055782A1 (en) * 2007-10-26 2009-04-30 Possis Medical, Inc. Intravascular guidewire filter system for pulmonary embolism protection and embolism removal or maceration
GB0802931D0 (en) 2008-02-18 2008-03-26 Queen Mary & Westfield College Synthetic scFv analogue to the 6313/G2 (anti angiotensin II type 1 receptor) monoclonal anitbody variable regions
JP2011111422A (ja) * 2009-11-27 2011-06-09 Sekisui Chem Co Ltd モノクローナル抗体
US11103263B2 (en) 2015-07-24 2021-08-31 Ichor Vascular Inc. Embolectomy system and methods of making and using same
CN115838425B (zh) * 2022-08-31 2024-06-18 首都医科大学 一种靶向血管紧张素ii 1型受体细胞外第二环的抗体及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4911909A (en) * 1987-01-02 1990-03-27 E. I. Du Pont De Nemours And Company Method of controlling hypertension using monoclonal antibodies to angiotensin-II
GB9319877D0 (en) * 1993-09-27 1993-11-10 Queen Mary Novel hybridoma & monoclonal antibodies produced thereby

Also Published As

Publication number Publication date
CA2170606A1 (en) 1995-04-06
CA2170606C (en) 2005-09-20
US6805864B1 (en) 2004-10-19
ATE202117T1 (de) 2001-06-15
JPH09509563A (ja) 1997-09-30
EP0725798A1 (de) 1996-08-14
AU7703294A (en) 1995-04-18
GB9319877D0 (en) 1993-11-10
US6063620A (en) 2000-05-16
EP0725798B1 (de) 2001-06-13
WO1995009186A1 (en) 1995-04-06
JP3727946B2 (ja) 2005-12-21
DE69427484T2 (de) 2002-09-12
AU695074B2 (en) 1998-08-06

Similar Documents

Publication Publication Date Title
DK1337629T3 (da) Dipeptidylpeptidaser
ATE427488T1 (de) Monoklonaler antikírper fur die inhibierung von hiv-1-hullgykoprotein-vermittelte membranfusion
ES2293973T3 (es) Anticuerpos anti-ccr2 humanizados y metodos de uso de los mismos.
DE69427484D1 (de) Angiotensin ii rezeptor typ i spezifische monoklonale antikörper und hybridoma
DE69429095T2 (de) Humanisierte antikoerper
NO20025354L (no) Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter
DE69230146T2 (de) Monoklonale antikörper gegen putative hcv-e2/ns1-proteine und verfahren zu ihrer verwendung
RS80704A (en) ANTI- av?6.ANTIBODIES
TR200100149T2 (tr) Dual anjiyotensin endotelin alıcı antagonistleri olarak bifenil-sülfonamitler
DE60224346D1 (de) Monoklonales Antikörper gegen das HCV Kernantigen
WO2001090358A3 (en) Mammalian receptor proteins; related reagents and methods
ATE267596T1 (de) Cyanidinzusammensetzungen und deren therapeutische und diagnostische verwendungen
PT759942E (pt) Receptor de interleucina-15
WO2001036467A3 (en) Mammalian receptor proteins; related reagents and methods
BR0116686A (pt) Anticorpos anti-cd28 silenciados e uso dos mesmos
DK0802924T3 (da) Lægemiddel til forlænget immunsuppression og eliminering af tumorceller
DE60041697D1 (de) Säugetier-rezeptorproteine; ähnliche reagentien und methoden
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
ATE248189T1 (de) Antikörper gegen vasp (vasodilator-stimulated phosphoprotein), hybridomzellen für deren gewinnung, und deren verwendung
YU13392A (sh) ANTITELA NA HUMANI RECEPTOR ZA IgE
WO2001057219A3 (en) Mammalian interleukin-1-delta and -epsilon. their use in therapeutic and diagnostic methods
NZ515382A (en) OX2 receptor homologs
WO2005065711A3 (en) Mammalian receptor proteins; related reagents and methods
BR0204612C1 (pt) anticorpos monoclonais antinúcleo de hcv
AR037216A1 (es) Anticuerpos monoclonales antinucleares de hcv

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication related to discontinuation of the patent is to be deleted
8364 No opposition during term of opposition